ADM Diagnostics
Northbrook
About ADM Diagnostics
ADMdx specializes in brain image analysis to enable diagnosis, prognosis, and drug effect detection for Alzheimer's disease and various other forms of dementia. We provide pharmaceutical companies with powerful information to improve clinical trial success. ADMdx provides image data analysis and full CNS imaging study services with structural MRI, amyloid PET, tau PET, FDG PET, ASL, fMRI BOLD, and DTI. We are developing diagnostic products to enable early, accurate disease detection supporting optimal patient care.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.9M
- Last round: Grant (Sep 2022)
- Website: admdx.com
- Phone: (847) 707-0370
Industries & Categories
Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/adm-diagnostics-13246 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.